🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 7 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/05/1999 | 68,94 | 69,00 | 67,75 | 67,99 | -2,40% | 1,82% | 4.020.442 |
| 13/05/1999 | 69,90 | 69,90 | 68,94 | 69,66 | +2,01% | 1,37% | 5.845.534 |
| 12/05/1999 | 68,23 | 69,95 | 67,27 | 68,28 | +0,00% | 3,93% | 7.658.365 |
| 11/05/1999 | 69,06 | 69,18 | 67,81 | 68,28 | -0,78% | 1,99% | 5.259.598 |
| 10/05/1999 | 70,13 | 70,25 | 68,46 | 68,82 | -3,19% | 2,55% | 4.502.208 |
| 07/05/1999 | 71,56 | 72,34 | 70,37 | 71,09 | +0,17% | 2,75% | 4.946.246 |
| 06/05/1999 | 69,48 | 71,21 | 69,18 | 70,97 | +2,15% | 2,92% | 5.263.266 |
| 05/05/1999 | 67,75 | 69,60 | 66,44 | 69,48 | +2,73% | 4,67% | 5.863.036 |
| 04/05/1999 | 67,63 | 69,66 | 67,03 | 67,63 | +0,27% | 3,88% | 6.595.798 |
| 03/05/1999 | 66,79 | 67,81 | 66,44 | 67,45 | +0,44% | 2,05% | 5.884.625 |
| 30/04/1999 | 67,75 | 68,52 | 65,84 | 67,15 | +0,00% | 3,96% | 7.782.972 |
| 29/04/1999 | 67,57 | 67,57 | 64,83 | 67,15 | -0,53% | 4,06% | 8.624.726 |
| 28/04/1999 | 69,18 | 69,60 | 66,91 | 67,51 | -3,82% | 3,88% | 7.653.963 |
| 27/04/1999 | 70,61 | 71,09 | 70,13 | 70,19 | -0,59% | 1,35% | 5.165.068 |
| 26/04/1999 | 71,56 | 71,62 | 69,90 | 70,61 | -2,31% | 2,42% | 6.627.342 |
| 23/04/1999 | 73,12 | 73,41 | 71,68 | 72,28 | -2,73% | 2,37% | 4.878.754 |
| 22/04/1999 | 72,22 | 74,67 | 70,61 | 74,31 | +2,64% | 5,62% | 6.385.464 |
| 21/04/1999 | 72,28 | 73,00 | 71,68 | 72,40 | +0,83% | 1,82% | 6.545.703 |
| 20/04/1999 | 70,61 | 73,35 | 70,31 | 71,80 | +2,91% | 4,31% | 7.595.380 |
| 19/04/1999 | 74,79 | 74,84 | 69,42 | 69,78 | -5,80% | 7,26% | 7.744.091 |
| 16/04/1999 | 72,70 | 75,86 | 71,68 | 74,07 | +0,32% | 5,74% | 11.062.898 |
| 15/04/1999 | 74,43 | 75,26 | 71,86 | 73,83 | -1,43% | 4,57% | 8.606.071 |
| 14/04/1999 | 78,13 | 78,42 | 74,19 | 74,90 | -5,56% | 5,42% | 5.494.454 |
| 13/04/1999 | 80,27 | 80,93 | 78,24 | 79,32 | -2,21% | 3,34% | 4.311.996 |
| 12/04/1999 | 79,32 | 81,17 | 79,08 | 81,11 | +2,10% | 2,63% | 4.018.137 |
| 09/04/1999 | 78,48 | 79,56 | 77,53 | 79,44 | +1,99% | 2,58% | 3.868.482 |
| 08/04/1999 | 76,28 | 78,66 | 76,10 | 77,89 | +1,79% | 3,36% | 5.151.130 |
| 07/04/1999 | 75,56 | 76,57 | 74,61 | 76,51 | +2,72% | 2,60% | 3.893.949 |
| 06/04/1999 | 74,61 | 75,92 | 74,19 | 74,49 | -0,16% | 2,32% | 3.799.105 |
| 05/04/1999 | 76,28 | 76,34 | 74,19 | 74,61 | -2,19% | 2,81% | 6.633.106 |